French Biotech Company Adipopharma Secures Funding To Initiate Clinical Trials For Its First-In-Class Compound For Insulin Resistance
Emmanuel Poteaux, Acting CEO of SATT Conectus, said:“The French biotech ecosystem has been following and supporting AdipoPharma closely for several years. We're excited for Dr. Marion and his team, as ...